Document is current
Any future updates will be listed below
-
Authors
François, Bruno
Jafri, Hasan S.
Bonten, Marc
- License Information
-
More Information
Article History
Received: 18 February 2016
Accepted: 21 March 2016
First Online: 31 March 2016
Compliance with ethical standards
:
: Bruno Francois is the coordinating principal investigator of an ongoing international phase II trial testing a monoclonal antibody against S. aureus to prevent VAP in ICU patients in collaboration with Medimmune, a member of the AstraZeneca group. No other conflict of interest related to this manuscript to declare. Hasan Jafri is an employee of MedImmune, AstraZeneca, the manufacturer of anti-infectious disease monoclonal antibodies. He is currently leading the development and conduct of studies focused on prevention of nosocomial pneumonia, using monoclonal antibodies targeting S. aureus and P. aeruginosa. No other conflict of interest related to this manuscript to declare. Marc Bonten is a member of the study team of an ongoing international phase II trial testing a monoclonal antibody against S. aureus to prevent VAP in ICU patients in collaboration with Medimmune, a member of the AstraZeneca group, as part of the IMI-funded COMBACTE and COMBACTE MAGNET projects. No other conflict of interest related to this manuscript to declare.
